Profound Medical (PROF) Equity Average (2019 - 2026)

Profound Medical's Equity Average history runs 8 years deep, the most recent figure standing at $62.9 million for Q1 2026.

• In Q1 2026, Equity Average rose 13.17% year-over-year to $62.9 million; the TTM figure through Mar 2026 stood at $62.9 million (up 13.17% YoY), while the FY2025 annual figure was $63.4 million, up 38.42% from the prior year.
• Equity Average was $62.9 million for Q1 2026 at Profound Medical, up from $49.3 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $66.6 million in Q4 2022 to a low of $34.8 million in Q3 2024.
• Historically, Equity Average has averaged $47.1 million across 5 years, with a median of $45.0 million in 2025.
• The sharpest annual moves came in 2023 and 2025: Equity Average sank 37.08% in 2023, then surged 44.92% in 2025.
• A 5-year view of Equity Average shows it stood at $66.6 million in 2022, then tumbled by 37.08% to $41.9 million in 2023, then gained by 8.73% to $45.6 million in 2024, then grew by 8.16% to $49.3 million in 2025, then increased by 27.67% to $62.9 million in 2026.
• The last three Equity Average figures came in at $62.9 million (Q1 2026), $49.3 million (Q4 2025), and $35.7 million (Q3 2025), per Business Quant data.